How Different Levels of CPAP Affect Oxygen Delivery and Lung Expansion in Preterm Infants
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
AgeNot listed
SponsorUniversity of Arkansas
About this trial
With this study, it is expected to learn more about preterm babies on breathing support with nasal continuous positive airway pressure (nCPAP). To gain more information on how much oxygen is actually delivered to the baby from the nCPAP machine.
Eligibility criteria
Qualifiers
Gestational age at birth must be less than 35 weeks of completed gestation as documented in the subject's initial history and physical
The infant must be stable while receiving nasal CPAP at any pressure level at the time of study
The infant must be receiving 22-40% at the time of the study
Disqualifiers
Oxygen requirements greater than 40% at time of enrollment
currently receiving invasive ventilation or not requiring ventilatory support
Major congenital anomalies of the heart and/or lungs
Trial design
Treatments tested in this trial
- Effective oxygen delivery and lung expansion measurement
Treatment groups
10 Participants
are divided into 1 treatment groupLocations
2University of Arkansas for Medical Sciences72205, Little RockArkansas, United States
University of Arkansas for Medical Sciences72205, Little RockArkansas, United States
Sponsors and collaborators
University of Arkansas
Lead sponsor
Source ClinicalTrials.gov